Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIA Fallopian Tube Cancer”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Large-scale testing (Phase 3)WithdrawnNCT00693342
What this trial is testing

Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Not applicableUnknownNCT01366183
What this trial is testing

Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Who this might be right for
Stage I Ovarian Cancer AJCC v6 and v7Stage IA Fallopian Tube Cancer AJCC v6 and v7Stage IB Fallopian Tube Cancer AJCC v6 and v7+13 more
Gynecologic Oncology Group 290
Testing effectiveness (Phase 2)Looking for participantsNCT05417594
What this trial is testing

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 695
Early research (Phase 1)WithdrawnNCT02833506
What this trial is testing

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+18 more
Roswell Park Cancer Institute
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Not applicableUnknownNCT01372787
What this trial is testing

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Who this might be right for
AnxietyFatigueNausea and Vomiting+20 more
Gynecologic Oncology Group 103
Large-scale testing (Phase 3)Active Not RecruitingNCT01167712
What this trial is testing

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Transitional Cell Carcinoma+27 more
National Cancer Institute (NCI) 692
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)WithdrawnNCT03735589
What this trial is testing

Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Stage II Fallopian Tube Cancer AJCC v8Stage II Ovarian Cancer AJCC v8Stage II Primary Peritoneal Cancer AJCC v8+31 more
Roswell Park Cancer Institute
Not applicableUnknownNCT00601406
What this trial is testing

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+7 more
The Christie NHS Foundation Trust 2,200
Very early researchStudy completedNCT01504126
What this trial is testing

Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+32 more
M.D. Anderson Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT00032162
What this trial is testing

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+2 more
AGO Study Group 63
Not applicableUnknownNCT00897039
What this trial is testing

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Southeastern Gynecologic Oncology 60
Large-scale testing (Phase 3)Active Not RecruitingNCT01081262
What this trial is testing

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

Who this might be right for
Borderline Ovarian Mucinous TumorOvarian Mucinous CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+21 more
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)UnknownNCT00719303
What this trial is testing

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+30 more
Gynecologic Oncology Group 1,070
Testing effectiveness (Phase 2)Study completedNCT00857545
What this trial is testing

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

Who this might be right for
Stage IA Fallopian Tube CancerStage IA Ovarian CancerStage IB Fallopian Tube Cancer+21 more
Gynecologic Oncology Group 171
Early research (Phase 1)Study completedNCT00989651
What this trial is testing

Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CarcinomaFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+35 more
National Cancer Institute (NCI) 431
Large-scale testing (Phase 3)Study completedNCT00951496
What this trial is testing

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+35 more
National Cancer Institute (NCI) 1,560
Testing effectiveness (Phase 2)Study completedNCT06087289
What this trial is testing

Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Novakand Pharma AB 18
Testing effectiveness (Phase 2)Study completedNCT01764802
What this trial is testing

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

Who this might be right for
Ovarian SarcomaOvarian Stromal CancerStage I Uterine Sarcoma+59 more
Ohio State University Comprehensive Cancer Center 100
Next Page